用于肝细胞癌治疗的射频消融术的最新进展
Recent advances in radiofrequency ablation for the management of hepatocellular carcinoma.
作者信息
Himoto Takashi, Kurokohchi Kazutaka, Watanabe Seishiro, Masaki Tsutomu
机构信息
Department of Integrated Medicine, Kagawa, Japan.
出版信息
Hepat Mon. 2012 Oct;12(10 HCC):e5945. doi: 10.5812/hepatmon.5945. Epub 2012 Oct 10.
Abstract
UNLABELLED
CONTEXTS: Hepatocellular carcinoma (HCC) is one of the most common malignant diseases in the world. Because less than 20% of patients with HCC are resectable, various types of non-surgical treatment have been developed.
EVIDENCE ACQUISITION
At present, radiofrequency ablation (RFA) is accepted as the standard local treatment for patients with HCC because of its superior local control and overall survival compared to other local treatments.
RESULTS
New devices for RFA and combination treatments of RFA with other procedures have been developed to improve anti-tumoral effects.
CONCLUSIONS
This review mainly focuses on the status of RFA in the management of HCC and recent advances in RFA treatment technology.
摘要
未标注
背景：肝细胞癌（HCC）是世界上最常见的恶性疾病之一。由于不到20%的HCC患者可进行手术切除，因此已开发出各种类型的非手术治疗方法。
证据获取
目前，射频消融（RFA）因其与其他局部治疗相比具有更好的局部控制和总生存率，被公认为HCC患者的标准局部治疗方法。
结果
已开发出用于RFA的新设备以及RFA与其他手术的联合治疗方法，以提高抗肿瘤效果。
结论
本综述主要关注RFA在HCC治疗中的现状以及RFA治疗技术的最新进展。
相似文献
1
Recent advances in radiofrequency ablation for the management of hepatocellular carcinoma.
Hepat Mon. 2012 Oct;12(10 HCC):e5945. doi: 10.5812/hepatmon.5945. Epub 2012 Oct 10.
2
The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review.
Ann Surg. 2009 Jan;249(1):20-5. doi: 10.1097/SLA.0b013e31818eec29.
3
Recent advances in radiofrequency ablation in the treatment of hepatocellular carcinoma and metastatic liver cancers.
Chang Gung Med J. 2009 Jan-Feb;32(1):22-32.
4
Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma.
Br J Surg. 2011 Sep;98(9):1210-24. doi: 10.1002/bjs.7669. Epub 2011 Jul 15.
5
No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
J Hepatol. 2018 Jun;68(6):1172-1180. doi: 10.1016/j.jhep.2018.01.014. Epub 2018 Feb 2.
6
Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
Eur Radiol. 2021 Jul;31(7):4764-4773. doi: 10.1007/s00330-020-07571-5. Epub 2021 Jan 5.
7
The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.
Oncology. 2020;98(12):859-868. doi: 10.1159/000508921. Epub 2020 Aug 14.
8
Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Eur Radiol. 2020 Nov;30(11):6357-6368. doi: 10.1007/s00330-020-06990-8. Epub 2020 Jun 11.
9
Treatment effect of radiofrequency ablation versus liver transplantation and surgical resection for hepatocellular carcinoma within Milan criteria: a population-based study.
Eur Radiol. 2021 Jul;31(7):5379-5389. doi: 10.1007/s00330-020-07551-9. Epub 2021 Jan 6.
10
[Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi. 2012 Apr;20(4):256-60. doi: 10.3760/cma.j.issn.1007-3418.2012.04.006.
引用本文的文献
1
Ablation for hepatocellular carcinoma: beyond the standard indications.
Med Oncol. 2020 Mar 12;37(4):23. doi: 10.1007/s12032-020-01348-y.
2
Dual-function of Baicalin in nsPEFs-treated Hepatocytes and Hepatocellular Carcinoma cells for Different Death Pathway and Mitochondrial Response.
Int J Med Sci. 2019 Sep 7;16(9):1271-1282. doi: 10.7150/ijms.34876. eCollection 2019.
3
Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization.
J Mater Sci Mater Med. 2015 Jun;26(6):198. doi: 10.1007/s10856-015-5530-3. Epub 2015 Jun 24.
4
Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma.
World J Hepatol. 2015 May 18;7(8):1054-63. doi: 10.4254/wjh.v7.i8.1054.
5
An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma.
Infect Agent Cancer. 2015 Mar 9;10:9. doi: 10.1186/s13027-015-0004-2. eCollection 2015.
6
Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patients.
J Cancer Res Clin Oncol. 2013 Dec;139(12):2021-33. doi: 10.1007/s00432-013-1530-1. Epub 2013 Sep 26.
7
Radiofrequency ablation during continuous saline infusion can extend ablation margins.
World J Gastroenterol. 2013 Feb 28;19(8):1278-82. doi: 10.3748/wjg.v19.i8.1278.
本文引用的文献
1
Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009).
Hepatol Res. 2010 Jul;40(7):667-85. doi: 10.1111/j.1872-034X.2010.00673.x.
2
Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma.
BMC Gastroenterol. 2010 Jul 9;10:78. doi: 10.1186/1471-230X-10-78.
3
Loco-regional treatment of hepatocellular carcinoma.
Hepatology. 2010 Aug;52(2):762-73. doi: 10.1002/hep.23725.
4
Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
Cancer. 2010 Aug 1;116(15):3638-44. doi: 10.1002/cncr.25142.
5
The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy.
J Gastroenterol Hepatol. 2010 Mar;25(3):439-52. doi: 10.1111/j.1440-1746.2009.06207.x.
6
Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.
Semin Liver Dis. 2010 Feb;30(1):3-16. doi: 10.1055/s-0030-1247128. Epub 2010 Feb 19.
7
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.
J Hepatol. 2010 Mar;52(3):380-8. doi: 10.1016/j.jhep.2009.12.004. Epub 2010 Jan 17.
8
Percutaneous radiofrequency ablation of hepatocellular carcinoma on cirrhosis: state of the art and future perspectives.
Recent Pat Anticancer Drug Discov. 2010 Jan;5(1):69-76. doi: 10.2174/157489210789702226.
9
Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
J Hepatobiliary Pancreat Surg. 2009;16(3):359-66. doi: 10.1007/s00534-009-0069-7. Epub 2009 Mar 20.
10
The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review.
Ann Surg. 2009 Jan;249(1):20-5. doi: 10.1097/SLA.0b013e31818eec29.
Zotero 插件